Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
25,816
Total Claims
$1.1M
Drug Cost
2,084
Beneficiaries
$511
Cost/Patient
Risk Score Breakdown 12/100
Score components are additive. Read full methodology
Peer Comparison vs. 1,498 Interventional Pain Management providers
+19%
Opioid rate vs peers
54.6% vs 45.9% avg
+6%
Cost per patient vs peers
$511 vs $483 avg
-16%
Brand preference vs peers
3.4% vs 4.1% avg
Opioid Prescribing
54.6%
Opioid Rate
14,102
Opioid Claims
$621K
Opioid Cost
8.9%
Long-Acting Rate
This provider's opioid prescribing rate of 54.6% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 890 claims · $479K
Generic: 24,926 claims · $585K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Hydrocodone/Acetaminophen | 6,675 | $151K |
| Oxycodone Hcl/Acetaminophen | 4,749 | $136K |
| Buprenorphine Hcl | 111 | $101K |
| Methylnaltrexone Bromide | 33 | $79K |
| Oxycodone Myristate | 106 | $64K |
| Pregabalin | 1,336 | $58K |
| Buprenorphine | 146 | $50K |
| Gabapentin | 3,523 | $46K |
| Naloxegol Oxalate | 105 | $44K |
| Oxycodone Hcl | 73 | $39K |
| Lidocaine | 319 | $35K |
| Suvorexant | 59 | $27K |
| Lubiprostone | 85 | $21K |
| Diclofenac Sodium | 495 | $20K |
| Linaclotide | 35 | $19K |
Prescribing Profile
45
Unique Drugs
12.0
Anomaly Score
Patient Profile
65
Avg Age
65%
Female
1.66
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About